{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:18:14Z","timestamp":1774678694066,"version":"3.50.1"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7065-25","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:10:26Z","timestamp":1774303826000},"source":"Crossref","is-referenced-by-count":0,"title":["Extrathymic malignancies in patients with myasthenia gravis: A Japanese multicenter study"],"prefix":"10.2169","author":[{"given":"Kazuki","family":"Yoshizumi","sequence":"first","affiliation":[{"name":"Department of Neurology, Hyogo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hyogo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hyogo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Igeta","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Hyogo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurology Chiba Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, The University of Osaka Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori P","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, The University of Osaka Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Sendai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Sendai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamichi","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Samukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Akamine","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manato","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Nagane","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hanamaki General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Neurology, International University of Health and Welfare, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiaki","family":"Utsugisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hanamaki General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Giat E, Ehrenfeld M, Shoenfeld Y. Cancer and autoimmune diseases. Autoimmun Rev 16: 1049-1057, 2017.","DOI":"10.1016\/j.autrev.2017.07.022"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14: 1023-1036, 2015.","DOI":"10.1016\/S1474-4422(15)00145-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Weksler B, Nason KS, Mackey D, Gallagher A, Pennathur A. Thymomas and extrathymic cancers. Ann Thorac Surg 93: 884-888, 2012.","DOI":"10.1016\/j.athoracsur.2011.05.089"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci 290: 66-69, 2010.","DOI":"10.1016\/j.jns.2009.11.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Filosso PL, Galassi C, Ruffini E, et al. Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study. Eur J Cardiothorac Surg 44: 219-224, 2013.","DOI":"10.1093\/ejcts\/ezs663"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pedersen EG, Potteg\u00e5rd A, Hallas J, et al. Myasthenia and risk of cancer: a population-based case-control study. Eur J Neurol 21: 773-778, 2014.","DOI":"10.1111\/ene.12383"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Liu CJ, Chang YS, Teng CJ, et al. Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study. Eur J Neurol 19: 746-751, 2012.","DOI":"10.1111\/j.1468-1331.2011.03621.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Verwijst J, Westerberg E, Punga AR. Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: a Swedish nationwide register study. Eur J Neurol 28: 1706-1715, 2021.","DOI":"10.1111\/ene.14730"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Citterio A, Beghi E, Millul A, et al. Risk factors for tumor occurrence in patients with myasthenia gravis. J Neurol 256: 1221-1227, 2009.","DOI":"10.1007\/s00415-009-5091-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Owe JF, Daltveit AK, Gilhus NE. Does myasthenia gravis provide protection against cancer? Acta Neurol Scand Suppl 183: 33-36, 2006.","DOI":"10.1111\/j.1600-0404.2006.00612.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Evoli A, Batocchi AP, Tonali P, Marciano M. Risk of cancer in patients with myasthenia gravis. Ann N Y Acad Sci 841: 742-745, 1998.","DOI":"10.1111\/j.1749-6632.1998.tb11011.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suzuki S, Masuda M, Uzawa A, et al. Japan MG registry: chronological surveys over 10 years. Clin Exp Neuroimmunol 14: 5-12, 2023.","DOI":"10.1111\/cen3.12731"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Welsh JS, Thurman SA, Howard SP. Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review. Clin Med Res 1: 227-232, 2003.","DOI":"10.3121\/cmr.1.3.227"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10: 7270-7275, 2004.","DOI":"10.1158\/1078-0432.CCR-04-0735"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pedersen EG, Potteg\u00e5rd A, Hallas J, et al. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine. Eur J Neurol 21: 454-458, 2014.","DOI":"10.1111\/ene.12329"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim YH, Shin HY, Kim SM. Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis. Yonsei Med J 60: 633-639, 2019.","DOI":"10.3349\/ymj.2019.60.7.633"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bonifati DM, Angelini C. Long-term cyclosporine treatment in a group of severe myasthenia gravis patients. J Neurol 244: 542-547, 1997.","DOI":"10.1007\/s004150050141"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Herman-Edelstein M, Rozen-Zvi B, Zingerman B, et al. Effect of immunosuppressive drugs on DNA repair in human peripheral blood mononuclear cells. Biomed Pharmacother 66: 111-115, 2012.","DOI":"10.1016\/j.biopha.2011.11.008"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 77: 1777-1782, 2004.","DOI":"10.1097\/01.TP.0000120181.89206.54"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med 377: 1824-1835, 2017.","DOI":"10.1056\/NEJMoa1709030"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7065-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:24:50Z","timestamp":1774668290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7065-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7065-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7065-25"}}